Citations Report

Cancer Science & Therapy : Citations & Metrics Report

Articles published in Cancer Science & Therapy have been cited by esteemed scholars and scientists all around the world.

Cancer Science & Therapy has got h-index 27, which means every article in Cancer Science & Therapy has got 27 average citations.

Following are the list of articles that have cited the articles published in Cancer Science & Therapy.

	2022	2021	2020	2019	2018
Year wise published articles	70	59	42	78	71
Year wise citations received	294	348	345	373	344

Journal total citations count	3968
Journal impact factor	2.06
Journal 5 years impact factor	2.85
Journal cite score	6.17
Journal h-index	27
Journal h-index since 2018	18

Important citations

Lorenzo VP, MendonÃƒÂ§a JÃƒÂºnior FJ, Scotti L, Scotti MT (2016) Theoretical Study of Phosphoethanolamine: A Synthetic Anticancer Agent with Broad Antitumor Activity. Journal of Chemistry. View at Publisher View at Google Scholar
Saxena R, Yang C, Rao M, Turaga RC, Garlapati C, at al. (2017) Preclinical development of a non-toxic oral formulation of monoethanolamine, a lipid precursor, for prostate cancer treatment. Clinical Cancer Research, clincanres-1716. View at Publisher View at Google Scholar
Naga Anusha P, Siddiqui A, Hima Bindu A (2011) Immuno Defense Mechanism against Tumors. J Cancer Sci Ther S 17: 2. View at Publisher View at Google Scholar
Arun Kumar R, Sathish Kumar D, Nishanth T (2011) A Review on Stem cell Research & Their Role in Various Diseases. J Stem Cell Res Ther 1(3: 1-5. View at Publisher View at Google Scholar
Karanova MV (2013) Influence of Low Temperature on the Evolution of Amino Acid Pools Adaptive Modifications inPoikilothermal Animals. International Journal of Biochemistry and Biophysics 1(2): 33-40. View at Publisher View at Google Scholar
Siddiqui A, Jeevani T, Naga Anusha P, Hima Bindu A (2011) Stem cell therapy for liver diseases. J Stem Cell Res Ther 1(111): 2. View at Publisher View at Google Scholar
Azevedo RA, Ferreira AK, Auada AV, Pasqualoto KF, et al. (2012) Antitumor effect of cationic INKKI peptide from bovine ÃŽÂ²-casein on melanoma B16F10. View at Publisher View at Google Scholar
Ferreira AK, Meneguelo R, Marques FL, Radin A, R Filho OM, et al. (2012) phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase. Biomedicine & Pharmacotherapy 66(7): 541-548. View at Publisher View at Google Scholar
Ferreira AK, Freitas VM, Levy D, Ruiz JL, Bydlowski SP (2013) Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine. PLoS One 8(3): e57937. View at Publisher View at Google Scholar
Ferreira AK, Freitas VM, Levy D, Ruiz JL, Bydlowski SP (2013 Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine. PLoS One 8(3): e57937. View at Publisher View at Google Scholar
Engel N, Lisec J, Piechulla B, Nebe B (2012 Metabolic profiling reveals sphingosine-1-phosphate kinase 2 and lyase as key targets of (phyto-) estrogen action in the breast cancer cell line MCF-7 and not in MCF-12A. PLoS One 7(10: e47833. View at Publisher View at Google Scholar
Tata A, Fernandes AM, Santos VG, Alberici RM, Araldi D (2012) Nanoassisted laser desorption-ionization-MS imaging of tumors. Analytical chemistry 84(15):6341-6345. View at Publisher View at Google Scholar
Ferreira AK, Meneguelo R, Pereira A, R FILHO OM, Chierice GO (2012) Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study. Anticancer research 32(1):95-104. View at Publisher View at Google Scholar
Pabst TM, Wendeler M, Wang X, Bezemer S, Hermans P, et al. (2017 affinity ligands enable separation of closely related biopharmaceuticals. Biotechnology Journal 12: 2 View at Publisher View at Google Scholar
Naga Anusha P, Siddiqui A, Hima Bindu A (2011) Immuno Defense Mechanism against Tumors. J Cancer Sci Ther S.17: 2. View at Publisher View at Google Scholar
Linke T, Aspelund MT, Thompson C, Xi G, Fulton A (2014) Development and scaleÃ¢â‚¬Âup of a commercial fed batch refolding process for an antiÃ¢â‚¬ÂCD22 two chain immunotoxin. Biotechnology progress 30(6): 1380-1389. View at Publisher View at Google Scholar
Linke T, Feng J, Yu K, Kim HJ, Wei Z et al. (2012) Process scale separation of an anti-CD22 immunotoxin charge variant. Journal of Chromatography A 1260: 120-125. View at Publisher View at Google Scholar
Burden RE, Caswell J, Fay F, Scott CJ (2012) Recent advances in the application of antibodies as therapeutics. Future medicinal chemistry 1:73-86. View at Publisher View at Google Scholar
Madhumathi J, Devilakshmi S, Sridevi S, Verma RS (2016) Immunotoxin therapy for hematologic malignancies: where are we heading?. Drug discovery today 21: 325-332. View at Publisher View at Google Scholar
Kawa S, Onda M, Ho M, Kreitman RJ, Bera TK, et al. (2011) The improvement of an anti-CD22 immunotoxin: conversion to single-chain and disulfide stabilized form and affinity maturation by alanine scan. InMAbs 3: 479-486. View at Publisher View at Google Scholar
Prev 1 2 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 Next »

Journal Highlights

Google Scholar citation report

Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

CAS Source Index (CASSI)
Index Copernicus
Google Scholar
Sherpa Romeo
Academic Journals Database
Open J Gate
Genamics JournalSeek
Academic Keys
JournalTOCs
China National Knowledge Infrastructure (CNKI)
CiteFactor
Scimago
Ulrich's Periodicals Directory
Electronic Journals Library
RefSeek
Hamdard University
EBSCO A-Z
Directory of Abstract Indexing for Journals
World Catalogue of Scientific Journals
OCLC- WorldCat
Scholarsteer
SWB online catalog
Virtual Library of Biology (vifabio)
Publons
MIAR
University Grants Commission
Geneva Foundation for Medical Education and Research

Cancer Science & Therapy